Enrolling By InvitationNCT07162467
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Observational studyAges 18–55China
Understand this study
What is this study about?
This study assesses thinking abilities.
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- TianjinSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 19, 2024
- Recruitment status
- Enrolling By Invitation
- Enrollment listed in the registry
- 200
- Sponsor
- Tianjin Anding Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- China
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT07162467
- Official title
Show the full official title
Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.
Recruitment & locations
By invitationThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Tianjin
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses thinking abilities.
Who is behind this study?
The study sponsor is Tianjin Anding Hospital, a hospital or academic medical center.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as enrolling by invitation.
